Pune Scientists Detects Cancer – Claims To Be World’s Fastest
A group of Pune-based researchers developed a ‘liquid biopsy’ technology to detect the early spread of cancer. They claim it is the world’s fastest technology to detect cancer.
Scientists added that the Central Drugs Standard Control Organisation had approved the ‘OncoDiscover’ technology.
Dr. Jayant Khandare, Chief Scientific Officer of Actorius Innovations and Research- A Pune based start-up, said that this new technology is expected to revolutionize the early diagnosis and management of cancer patients in India.
Actorius has indigenously discovered the more specific, highly rapid, and efficient cancer diagnostic technology in detecting the early spread of cancers added Dr. Khandare.
The Pune based start-up has been funded for high-risk innovations by the Biotechnology Industry Research Assistance Council (BIRAC), an industry support wing of the Department of Biotechnology Dr. Jayant added.
Pune Scientists Detects Cancer- The Researchers
A team of researchers led by Dr. Khandare and Aravindan Vasudevan worked to crack the technological issues in detecting circulating tumor cells (CTCs) from lung, breast, colorectal, head, and neck cancers.
The new technology developed by the Pune Startup has been patented internationally and ‘clinically validated’ via multiple clinical trials. One such clinical trial was undertaken by Dr. Pankaj Chaturvedi, a renowned oncologist and deputy director at the Tata Memorial Hospital (TMH) in Mumbai.
While the United States approves a similar CTC detection test FDA costs $1,000 and is unaffordable for most Indians, OncoDiscover has developed the technology which is available at a fraction of that cost.
Pune Scientists Detects Cancer- Where Is This Available?
The newly discovered test is now available in Pune at the OncoDiscover Liquid Biopsy Technology lab for cancer patients in India.
Dr. Jayant Khandare was awarded the Alexander von Humboldt Experienced Researcher Fellowship in 2011 for his research in macromolecular chemistry, involving work on targeting cancer cells and in inflammation using ligands and hyper-branched polymers.
The Germany-based Humboldt Foundation gives this award, and 44 of the awardees have gone on to win the Nobel Prize